Organization of Personalized Medicine

  • Kewal K. JainEmail author


Development of personalized medicine is a multidisciplinary undertaking and will need teamwork by many players. Pharmaceutical and biotechnology companies have taken a leading role in this venture in keeping with their future as healthcare enterprises rather than mere developers of technologies and manufacturers of medicines. The practicing physicians will play a vital role in implementing personalized medicine. Various players in the development of personalized medicine are listed in Table 151.1. The Personalized Medicine Coalition (PMC) contains many of these players.


Personalized Medicine Process Analytical Technology Personalized Healthcare Montreal Heart Institute Independent Software Vendor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Gurwitz D, Weizman A, Rehavi M (2003) Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol Sci 24:122–125CrossRefPubMedGoogle Scholar
  2. Jain KK (2006b) Challenges of developing personalized medicines. Curr Opin Mol Ther 8:487–492Google Scholar
  3. Kohane IS, Masys DR, Altman RB (2006) The incidentalome: a threat to genomic medicine. JAMA 296:212–215CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Jain PharmaBiotechBaselSwitzerland

Personalised recommendations